How much does one dose of margituximab cost? What's the price difference for different specifications?

Margetuximab (Margetuximab) is a targeted therapy drug mainly used to treat HER2 positive breast cancer and gastric cancer. Currently, the original drug of margetuximab has been launched in China, but due to its short time on the market, the specific market price has not yet been fully clarified, and it has not yet been included in medical insurance. Therefore, patients need to consult local hospital pharmacies or related medical institutions for the latest price information when purchasing. Because the drug is still in the new launch stage, its price may be subject to certain uncertainty, and as the market matures, the price may fluctuate.

In overseas markets, especially in Europe and Japan, the original drug of margituximab has been launched, and the common specification is 250mg/10ml*1bottle/box. Depending on the region and sales channel, the price of drugs of this specification is approximately more than 30,000 yuan. Although prices may fluctuate in different countries and regions, the overall prices are relatively consistent, and in some countries, the market price of original drugs may be higher than the domestic market. When patients choose to purchase, they can consider obtaining drugs through international drug channels, but they need to ensure the quality and legality of the drugs.

For patients, the price difference is mainly reflected in the different specifications of drugs. At present, the common specifications of margituximab are 250mg/10ml*1 bottle/box, but if other specifications (such as bottles of drugs with different dosages) are launched in the future, the price may be adjusted. The price difference between drugs of different specifications depends on factors such as the dosage of the drug, production costs, and market demand. Therefore, when purchasing, patients should communicate with their doctors to choose the specifications that best suit their condition and financial situation.

As of now, there are no generic versions of margetuximab on the market. While some generic drugs may be launched in the future, currently only brand-name drugs are available. Therefore, when patients purchase margetuximab, they need to pay special attention to the source and quality of the drug to ensure the safety and effectiveness of the treatment. When choosing purchase channels, patients should obtain drugs through formal channels and avoid purchasing counterfeit and substandard drugs through unknown channels.

Reference materials:https://www.margenza.com/